Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza A/Bethesda/MM2/H1N1 Challenge Study
NCT04044352Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Percentage of Healthy Participants Reporting Mild-to-Moderate Influenza Disease and Association Between Clinical or Laboratory Manifestation of MMID and HAI Antibodies. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT04044352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04044352.